The following slide summarizes the full-year performance: Arjo’s gross margin decline was attributed to several factors, including significant currency headwinds, US tariffs, unfavorable product and ...
Arjo AB reported its fourth-quarter 2025 earnings, revealing a decline in key financial metrics, which led to a significant drop in its stock price. The company’s revenue fell to SEK 11 billion, while ...
Arjo AB (STO:ARJO B), a global medical technology company specializing in mobility solutions for healthcare settings, presented its Q4 and full-year 2025 results on January 30, 2026, revealing a mixed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results